• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

炎症性肠病患病率不断上升，凸显出对有效且具成本效益疗法的需求。

Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies.

机构信息

Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Division of Gastroenterology, University of California Davis, Sacramento, CA, USA.

出版信息

Inflamm Bowel Dis. 2020 Mar 4;26(4):626-627. doi: 10.1093/ibd/izz203.

DOI:10.1093/ibd/izz203
PMID:31854449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7327157/
Abstract

The prevalence of inflammatory bowel disease and costs of care are rising in the United States and highlight the need for effective, cost-effective therapies.

摘要

在美国，炎症性肠病的患病率和治疗费用不断上升，这凸显了对有效且具有成本效益的治疗方法的需求。

相似文献

1
Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies.炎症性肠病患病率不断上升，凸显出对有效且具成本效益疗法的需求。
Inflamm Bowel Dis. 2020 Mar 4;26(4):626-627. doi: 10.1093/ibd/izz203.
2
Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review.美国炎症性肠病相关成本和具有成本效益的策略：综述。
Inflamm Bowel Dis. 2011 Jul;17(7):1603-9. doi: 10.1002/ibd.21488. Epub 2010 Nov 4.
3
Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.美国2007 - 2016年大型国家数据库中儿童和成人炎症性肠病的患病率：近期估计
Inflamm Bowel Dis. 2020 Mar 4;26(4):619-625. doi: 10.1093/ibd/izz182.
4
Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.哥伦比亚基于全国代表性索赔数据库的人口统计学和地区炎症性肠病流行病学趋势以及对哥伦比亚患者病例系列中炎症性肠病表型的特征描述。
Medicine (Baltimore). 2021 Feb 19;100(7):e24729. doi: 10.1097/MD.0000000000024729.
5
Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.美国系统性红斑狼疮或炎症性肠病患儿和青年人群的医疗保健利用情况和合并症负担。
J Pediatr. 2012 Oct;161(4):662-670.e2. doi: 10.1016/j.jpeds.2012.03.045. Epub 2012 May 10.
6
Mental Health Costs of Inflammatory Bowel Diseases.炎症性肠病的心理健康成本
Inflamm Bowel Dis. 2021 Jan 1;27(1):40-48. doi: 10.1093/ibd/izaa030.
7
Psoriasis increases the risk of concurrent inflammatory bowel disease: A population-based nationwide study in Korea.银屑病增加了并发炎症性肠病的风险：一项基于韩国全国人口的研究。
Indian J Dermatol Venereol Leprol. 2019 Mar-Apr;85(2):145-152. doi: 10.4103/ijdvl.IJDVL_875_17.
8
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease.用于炎症性肠病研究的全科医疗研究数据库的有效性和完整性。
Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):211-8. doi: 10.1002/pds.698.
9
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data.加拿大安大略省儿童炎症性肠病发病率上升：来自卫生行政数据的证据。
Gut. 2009 Nov;58(11):1490-7. doi: 10.1136/gut.2009.188383. Epub 2009 Aug 2.
10
Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database.匈牙利炎症性肠病的全国患病率及药物治疗实践：一项基于国家健康保险基金数据库的人群研究。
Dig Liver Dis. 2016 Nov;48(11):1302-1307. doi: 10.1016/j.dld.2016.07.012. Epub 2016 Jul 21.

引用本文的文献

1
Regional Trends in Inflammatory Bowel Disease-Related Mortality in the US from 1999 to 2022.1999年至2022年美国炎症性肠病相关死亡率的地区趋势
Clin Exp Gastroenterol. 2025 Apr 24;18:55-66. doi: 10.2147/CEG.S513012. eCollection 2025.
2
Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.心血管合并症与炎症性肠病：病因与后果
Gastroenterol Hepatol (N Y). 2024 Apr;20(4):204-215.
3
Clinical Significance of Serum Elafin in Children with Inflammatory Bowel Disease.血清弹性蛋白酶在炎症性肠病患儿中的临床意义
Biomedicines. 2022 Dec 16;10(12):3267. doi: 10.3390/biomedicines10123267.
4
Starch nanoparticles improve curcumin-induced production of anti-inflammatory cytokines in intestinal epithelial cells.淀粉纳米颗粒可改善姜黄素诱导的肠道上皮细胞抗炎细胞因子的产生。
Int J Pharm X. 2022 Mar 8;4:100114. doi: 10.1016/j.ijpx.2022.100114. eCollection 2022 Dec.
5
Pioglitazone-Mediated Attenuation of Experimental Colitis Relies on Cleaving of Annexin A1 Released by Macrophages.吡格列酮介导的实验性结肠炎缓解依赖于巨噬细胞释放的膜联蛋白A1的裂解。
Front Pharmacol. 2020 Dec 21;11:591561. doi: 10.3389/fphar.2020.591561. eCollection 2020.
6
Identifying Patients With Inflammatory Bowel Diseases in an Administrative Health Claims Database: Do Algorithms Generate Similar Findings?在行政健康索赔数据库中识别炎症性肠病患者：算法得出的结果相似吗？
Inquiry. 2019 Jan-Dec;56:46958019887816. doi: 10.1177/0046958019887816.

本文引用的文献

1
Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.美国2007 - 2016年大型国家数据库中儿童和成人炎症性肠病的患病率：近期估计
Inflamm Bowel Dis. 2020 Mar 4;26(4):619-625. doi: 10.1093/ibd/izz182.
2
Opportunistic Infections Are More Prevalent in Crohn's Disease and Ulcerative Colitis: A Large Population-Based Study.机会性感染在克罗恩病和溃疡性结肠炎中更为普遍：一项基于大人群的研究。
Inflamm Bowel Dis. 2020 Jan 6;26(2):291-300. doi: 10.1093/ibd/izz147.
3
IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology.苏格兰洛锡安区基于捕捉-再捕获法推算的 IBD 患病率。
Gut. 2019 Nov;68(11):1953-1960. doi: 10.1136/gutjnl-2019-318936. Epub 2019 Jul 11.
4
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.炎症性肠病的成本：来自克罗恩病和结肠炎基金会的倡议。
Inflamm Bowel Dis. 2020 Jan 1;26(1):1-10. doi: 10.1093/ibd/izz104.
5
Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.1970年至2010年明尼苏达州奥尔姆斯特德县克罗恩病和溃疡性结肠炎的发病率及患病率
Clin Gastroenterol Hepatol. 2017 Jun;15(6):857-863. doi: 10.1016/j.cgh.2016.10.039. Epub 2016 Nov 14.
6
Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015.18 岁及以上成年人炎症性肠病的患病率 - 美国，2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Oct 28;65(42):1166-1169. doi: 10.15585/mmwr.mm6542a3.
7
Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population.美国商业保险人群中克罗恩病和溃疡性结肠炎患病率的近期趋势。
Dig Dis Sci. 2013 Feb;58(2):519-25. doi: 10.1007/s10620-012-2371-5. Epub 2012 Aug 29.